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Abstract
Mitogen-activated protein kinases (MAPK) are integration points for multiple biochemical signals. 
We evaluated 13 MAPK genes with breast cancer risk and determined if diet and lifestyle factors 
mediated risk. Data from three population-based case-control studies conducted in Southwestern 
United States, California, and Mexico included 4183 controls and 3592 cases. Percent Indigenous 
American (IA) ancestry was determined from 104 Ancestry Informative Markers. The adaptive 
rank truncated product (ARTP) was used to determine the significance of each gene and the 
pathway with breast cancer risk, by menopausal status, genetic ancestry level, and ER/PR strata.
MAP3K9 was associated with breast cancer overall (PARTP=0.02) with strongest association 
among women with the highest IA ancestry (PARTP=0.04). Several SNPs in MAP3K9 were 
associated with ER+/PR+ tumors and interacted with dietary oxidative balance score (DOBS), 
dietary folate, body mass index (BMI), alcohol consumption, cigarette smoking, and a history of 
diabetes. DUSP4 and MAPK8 interacted with calories to alter breast cancer risk; MAPK1 
interacted with DOBS, dietary fiber, folate and BMI; MAP3K2 interacted with dietary fat; and 
MAPK14 interacted with dietary folate and BMI. The patterns of association across diet and 
lifestyle factors with similar biological properties for the same SNPs within genes provide support 
for associations.
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Mitogen-activated protein kinases (MAPK) act as integration points for multiple 
biochemical signals and are involved in a variety of cellular processes, including cell 
proliferation, differentiation, transcription regulation and development [1]. By 
phosphorylating transcription factors, kinases and other enzymes, they influence gene 
expression, metabolism, cell division, morphology, and survival. Each MAPK pathway is a 
three-tiered cascade that includes a MAP kinase kinase kinase (MAP3K, MEKK, or 
MKKK), Map kinase kinase (MAP2K, MEK, or MKK), and the MAP kinase (MAPK). 
MAPKs are attenuated by dual specificity MAPK phosphatases (MKPs or DUSP). Three of 
the major MAPK pathways are extracellular regulated kinases (ERK), c-Jun-N-terminal 
kinases (JNKs) sometimes called stress-activated protein kinases (SAPK), and p38 [2]. 
Deregulation of the MAPK pathways has been associated with a variety of diseases such as 
cancer and type-2 diabetes and with inflammation [3–5].
MAPK pathways are activated by various environmental stimuli, cytokines, and hormones. 
ERK1 and ERK2 are activated by stimuli such as growth factors and cytokines [1]. The JNK 
pathway is involved in regulating responses to stress, inflammation, and apoptosis and are 
activated by radiation, environmental stresses, and growth factors. The JNK pathway has 
been shown to be involved in the development of obesity and type 2 diabetes [3,4]. The p38 
MAPKs have been linked to autoimmunity in humans and are activated by chemical 
stresses, hormones, cytokines including IL-1 and TNF, and oxidative stress [1,2]. MAPK 
mediate several signaling pathways associated with cancer, including IL1, IκBK, NFκB, 
PPARγ, TNFα, and TGFβ, and BMP [6–10].
Dietary factors likely affect many of these pathways through their antioxidant and pro-
oxidant properties as well as possibly influencing growth factors and insulin through energy-
contributing nutrients [11]. Lifestyle factors, including body size, cigarette smoking, 
alcohol, and diabetes may also affect the MAPK signaling pathway through their association 
with inflammation, oxidative stress, and insulin. Body size has been associated with breast 
cancer with most studies showing an inverse association with pre-menopausal women and a 
slight increased risk among post-menopausal women [12–15]; in Latina women obesity has 
been shown to be inversely associated with both pre- and post-menopausal [16,17]. 
Cigarette smoking has been inconsistently associated with breast cancer risk [18,19], while 
alcohol has been shown to slightly increase risk in most populations [20–23]. Few studies 
have evaluated diabetes robustly with breast cancer risk, although it has been hypothesized 
that insulin resistance influences breast cancer risk [24–27]. Associations with dietary intake 
varies and studies have suggested differences in effect for several nutrients among Latina 
women [20,28].
In this study we evaluated the association between genetic variation in key MAPK genes and 
the risk of breast cancer in a genetically admixed population living in the Southwestern 
United States, California, and Mexico. We investigated associations between the MAPK 
genes and the risk of breast cancer was modified by potential activators of the pathway such 
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as dietary factors, body mass index (BMI), alcohol intake, cigarette smoking status, and 
having been diagnosed with diabetes. We hypothesize that MAPK genes are associated with 
breast cancer and that these associations are modified by diet and lifestyle factors as well as 
by IA ancestry and ER/PR tumor status.
Methods
The Breast Cancer Health Disparities Study includes participants from three population-
based case-control studies, the 4-Corners Breast Cancer Study (4-CBCS), the Mexico Breast 
Cancer Study (MBCS), and the San Francisco Bay Area Breast Cancer Study (SFBCS) who 
completed an in-person interview and who had a blood or mouthwash sample available for 
DNA extraction [17,29–31]. All participants signed informed written consent prior to 
participation and each study was approved by the Institutional Review Board for Human 
Subjects.
4 Corner’s Breast Cancer Study
Participants were NHW, Hispanic, or Native American women living in non-reservation 
areas in the states of Arizona, Colorado, New Mexico, or Utah at the time of diagnosis or 
selection [17]. Eligible female breast cancer cases were between 25 and 79 years of age with 
a histological confirmed diagnosis of in situ (n=337) or invasive cancer (n=1466) (ICDO 
sites C50.0-C50.6 and C50.8-C50.9) between October 1999 and May 2004. Controls were 
selected from the target populations and were frequency matched to cases on the expected 
ethnicity and 5-year age distribution. In Arizona and Colorado controls under age 65 years 
were randomly selected from a commercial mailing list; in New Mexico and Utah they were 
randomly selected from driver’s license lists. In all states, women 65 years and older were 
randomly selected from Center for Medicare Services lists. Women were screened by 
telephone for eligibility and self-identified their race/ethnicity prior to study enrollment. Of 
cases contacted, 852 Hispanic, 22 American Indian, and 1683 NHW women participated. Of 
controls contacted, 913 Hispanic, 23 American Indian, and 1669 NHW women participated. 
Blood was collected and DNA extracted for 76% of participants in Arizona, 71% of 
participants in Colorado, 75% of participants in New Mexico, and 94% of participants in 
Utah.
Mexico Breast Cancer Study
Participants were between 28 and 74 years of age, living in one of three states, Monterrey, 
Veracruz and Mexico City, for the past five years as previously described [32]. Eligible 
cases were women diagnosed with either a new histologically confirmed in situ or invasive 
breast cancer between January 2004 and December 2007 at 12 participating hospitals from 
three main health care systems in Mexico, IMSS, ISSTE, and SS. In situ and invasive 
cancers were not distinguished in the study database. Controls were randomly selected from 
the catchment area of the 12 participating hospitals using a probabilistic multi-stage design. 
A total of 1000 cases and 1074 controls were recruited, and blood was collected and DNA 
extracted from 85% and 96% of women respectively.
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San Francisco Bay Area Breast Cancer Study
Participants were Hispanic, African American, and NHW women aged 35 to 79 from the 
San Francisco Bay Area diagnosed with a first primary histologically confirmed invasive 
breast cancer between 1995 and 2002; controls were identified by random-digit dialing 
(RDD) [30,31]. This analysis was limited to women who participated in the biospecimen 
component of the parent study that was initiated in 1999 [33]. Eligible cases were Hispanic 
women diagnosed between April 1997 and April 2002 and a 10% random sample of NHW 
women diagnosed between April 1997 and April 1999. RDD controls were frequency-
matched to cases based on race/ethnicity and the expected 5-year age distribution of cases. 
Women participated in a telephone screening interview that assessed study eligibility and 
self-identified race/ethnicity. DNA was available for 93% of cases and 92% of controls 
interviewed, including 1105 cases (793 Hispanics, 312 NHW) and 1318 controls (998 
Hispanics, 320 NHW).
Data Harmonization
Data were harmonized across all study centers and questionnaires as previously described 
[29]. Women were classified as either pre-menopausal or post-menopausal based on 
responses to questions on menstrual history. Women who reported still having periods 
during the referent year (defined as the calendar year before diagnosis for cases or before 
selection into the study for controls) were classified as pre-menopausal. Women were 
classified as post-menopausal if they reported either a natural menopause or if they reported 
taking hormone therapy (HT) and were still having periods and were at or above the 95th 
percentile of age for those who reported having a natural menopause (i.e., >12 months since 
their last period).
Lifestyle variables included body mass index (BMI) calculated as self-reported weight (kg) 
during the referent year divided by measured height squared (m2). Parity was defined as the 
number of total pregnancies. Cigarette smoking was evaluated as ever versus never having 
smoked cigarettes on a regular basis or more than 100 cigarettes. Those classified as having 
a history of diabetes reported being told by a doctor or health professional that they had 
diabetes or high blood sugar. A dietary oxidative balance score (DOBS) that included 
nutrients with anti- or pro-oxidative balance properties was developed as previously reported 
[34]. Dietary information was collected via a computerized validated diet history 
questionnaire for the 4-CBCS [35,36], a 104-item semi-quantitative Food Frequency 
Questionnaire (FFQ) in Mexico City [37], and the Block Food Frequency Questionnaire in 
SFBCS [38]. The food frequency questionnaire used in the 4-CBCS queries consumption of 
foods in major categories and if that is yes, then more detail about specific foods are 
obtained. For instance, a question would ask “Do you eat eggs?” If the response is yes, then 
details of types of eggs and related frequency and amount for each type were obtained. The 
FFQ asked a list of food items and participants provide information for each food item in the 
list. Given differences in food questionnaires, categories of consumption were study 
specific.
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DNA was derived from either whole blood or mouthwash samples obtained from study 
participants. A total of 7286 blood-derived and 637 mouthwash-derived samples were 
studied. Whole Genome Amplification (WGA) was applied to the mouthwash-derived DNA 
samples prior to genotyping. A tagSNP approach was used to characterize variation across 
candidate genes. TagSNPs were selected using the following parameters: linkage 
disequilibrium (LD) blocks were defined using a Caucasian LD map and an r2=0.8; minor 
allele frequency (MAF) >0.1; range= −1500 bps from the initiation codon to +1500 bps 
from the termination codon; and 1 SNP/LD bin. For genes where a functional SNP was 
identified, that SNP was included in the platform. Additionally, 104 Ancestral Informative 
Markers (AIMs) were used to distinguish European and Native American ancestry in the 
study population [29]. All markers were genotyped using a multiplexed bead array assay 
format based on GoldenGate chemistry (Illumina, San Diego, California). A genotyping call 
rate of 99.93% was attained (99.65% for WGA samples). We included 132 internal 
replicates that were blinded representing 1.6% of the sample set. The duplicate concordance 
rate was 99.996% as determined by 193,297 matching genotypes among sample pairs. In the 
current analyses we evaluated DUSP4 (6 SNPs), DUSP6 (1 SNP), MAP2K1 (6 SNPs), 
MAP3K1 (7 SNPs), MAP3K2 (3 SNPs), MAP3K3 (2 SNPs), MAP3K7 (6 SNPs), MAP3K9 
(19 SNPs), MAPK1 (6 SNPs), MAPK3 (1 SNP), MAPK8 (4 SNPs), MAPK12 (2 SNPs), and 
MAPK14 (9 SNPs). Genes and SNPs are described in online Supplements 1 and 2.
Tumor Characteristics
Data for ER/PR tumor status were available from local tumor registries for cases from the 4-
CBCS and the SFBCS for 1019 (69%) non-Hispanic white (NHW) and 977 (75%) Hispanic/
Native American (NA) women.
Statistical Methods
The program STRUCTURE was used to compute individual ancestry for each study 
participant assuming two founding populations [39,40]. A two-founding population model 
was used. Assessment across categories of ancestry was done using cut-points based on the 
distribution of genetic ancestry in the control population. Three strata, ≤28%, >28–70%, and 
>70%, were used to evaluate associations by level of Indigenous American (IA) ancestry. 
Cut-points were chosen to maximize power within the three ancestry groups while 
maintaining the ability to discriminate unique ancestry groups.
P values are based on chi-square tests when comparing number of cases to controls by 
categorical variables and on Wilcoxon Rank Sum tests when measuring differences in 
median values. Genes and SNPs were assessed for their association with breast cancer risk 
by strata of menopausal status and genetic ancestry in the whole population and by ER/PR 
status for the SFBCS and 4-CBCS. Statistical analyses were performed using SAS version 
9.3 (SAS Institute, Cary, NC) unless otherwise noted. Logistic regression models were used 
to estimate odds ratios (OR) and 95% confidence intervals (CI) for breast cancer risk 
associated with SNPs, adjusting for five-year age categories (continuous), study center, 
genetic ancestry (continuous), BMI during referent year (continuous), and parity 
(continuous). Age and study center were matching variables and therefore adjusted in the 
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analysis. BMI and parity were included as adjustment variables given their association with 
breast cancer and possible association with genes being examined.The generalized logit link 
function was used when estimating risk by ER/PR status. Associations with SNPs were 
assessed assuming a co-dominant model. Based on the initial assessment, SNPs which 
appeared to have a dominant or recessive mode of inheritance were evaluated with those 
inheritance models in subsequent analyses.
We used the adaptive rank truncated product (ARTP) method that is based on a highly 
efficient permutation algorithm to determine the significance of association of each gene and 
of the pathway with breast cancer overall, by menopausal status, by genetic ancestry level, 
and by ER/PR strata. The gene p values were generated using the ARTP package in R, 
permuting outcome status 10,000 times while adjusting for age, BMI during referent year, 
and genetic ancestry [41,42]. We report both pathway and gene p values (PARTP) as an 
indicator of the importance of the gene and the overall pathway with breast cancer risk.
We examined if the association between SNPs and risk of breast cancer was different by 
menopausal status, ER and PR tumor status, level of IA ancestry, and diet and lifestyle 
factors. Diet and lifestyle factors were selected based on their potential to modify factors 
associated with oxidative stress, inflammation, growth factors, and/or insulin and 
categorized to test for interactions. For stratified analyses, tests for interactions were 
calculated using a Wald 1-degree of freedom (1-df) chi-square tests; overall SNP 
associations with breast cancer by ER/PR status are estimated using p values from 4-df 
Wald tests. Adjustments for multiple comparisons for stratified analyses within the gene 
used the step-down Bonferroni correction (i.e., Holm method) taking into account the 
correlated nature of the data using the SNP spectral decomposition method proposed by 
Nyholt and modified by Li and Ji [43,44]. We report both the unadjusted and adjusted p 
values for interactions between genes and diet and lifestyle factors.
Results
The majority of women were post-menopausal at the time of diagnosis (Table 1). Almost all 
women (over 99%) who self-identified as being NHW had low levels of IA ancestry 
(≤28%), while those who self-identified as being Hispanic or Native American or who lived 
in Mexico, had a range of IA levels, although the majority had intermediate and high IA 
ancestry (>28%). Almost 50% of NHW women reported never drinking alcohol, compared 
to 78% of Hispanic/IA controls and 73% of Hispanic/NA cases reported never drinking 
alcohol. Among Hispanic/NA women, total calories was significantly higher among cases 
than controls and dietary fiber, folate, vitamin E, and beta carotene were significantly lower 
among cases than controls.
The overall pathway was not statistically significant overall or for any admixture group. 
Only MAP3K9 was significantly associated with breast cancer risk overall (PARTP=0.02) 
and for women with the highest level of IA ancestry (PARTP=0.04) (Table 2). Several 
MAP3K9 SNPs were significantly associated with breast cancer among all women and/or by 
strata of IA ancestry (rs11628333, rs10483834, rs11622989, rs12883244, rs11158881, 
rs4902855, rs10143031, and rs11624934). MAP3K3 rs3785574 and MAPK8 rs10508901 
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associations with breast cancer were significantly different across ancestry group although 
neither of the genes was statistically significant by the ARTP p value. We did not observe 
differences in breast cancer associations by menopausal status.
Significant differences in breast cancer risk were identified by ER/PR tumor status (Table 
3).). The pathway PARTP was of borderline significance for ER−/PR− tumors (PARTP=0.06). 
MAP3K3 was significantly associated with ER−/PR− tumors (PARTP=0.002) and MAP3K3 
rs3785574 was significantly associated with these tumors (OR 1.74, 95% CI 1.26, 2.39). 
MAP3K9 was significantly associated with ER+/PR+ tumors (PARTP=0.01) based on 
significant associations with several SNPs (rs11622989, rs17176971, rs12883244, 
rs4902855, and rs11624934). MAPK3 was significantly associated with ER+/PR− tumors 
(PARTP=0.048) with rs7698 being inversely associated with breast cancer risk (OR 0.65, 
95% CI 0.43, 0.99).
Assessment of dietary factors that could modify associations between MAPK genes and 
breast cancer risk showed several significant interactions (Table 4). DUSP4 (1 SNP), 
MAP3K7 (1 SNP), MAP3K9 (2 SNPs), MAPK14 (1 SNP), and MAPK1 (3 SNPs) interacted 
with the DOBS. High DOBS reduced breast cancer risk for those with the homozygote 
common genotype. DUPS4 (3 SNPs), MAP3K1 (1 SNP), MAPK8 (2 SNPs), and MAPK3 (1 
SNP) interacted with total caloric intake; fewer calories generally reduced breast cancer risk 
among women with the homozygote rare alleles. MAP3K2 (2 SNPs) interacted with dietary 
fat; a high fat diet and having the CC genotype of rs12613413 increased breast cancer risk, 
while a high fat diet decreased breast cancer risk among women with the TT genotype of 
rs6732279. MAPK8 (1 SNP) and MAPK1 (4 SNPs) interacted with dietary fiber; high intake 
of dietary fiber generally reducing breast cancer risk among women with the homozygote 
common genotype. Dietary folate interacted with DUSP4 (1 SNP), MAP3K7 (1 SNP), 
MAP3K9 (4 SNPs), MAPK8 (1 SNP), MAPK14 (2 SNPs), and MAPK1 (3 SNPs); reduced 
breast cancer risk was observed for the homozygote common genotype in the presence of 
high folate..
When evaluating the interaction of MAPK genes and BMI we saw different sets of genes 
interacting with BMI to alter risk of pre-menopausal breast cancer versus post-menopausal 
breast cancer (Table 5). Among pre-menopausal breast cancer cases DUSP4 (1 SNP), 
MAP3K9 (5 SNPs), MAPK8 (1 SNP), and MAPK1 (2 SNPs) interacted with BMI, while 
among post-menopausal women BMI interacted with MAPK1 (1 SNP), MAP3K3 (1 SNP), 
MAP3K9 (1 SNP), and MAPK14 (2 SNPs). MAP3K9 rs11622989 and rs12883244 interacted 
with both alcohol intake and cigarette smoking. High alcohol intake was associated with 
increased risk among women with the homozygote common genotype of DUSP4 rs474824; 
cigarette smoking most strongly increased risk among women with the homozygote rare 
genotype of MAPK14 rs13196204. A history of diabetes interacted with 11 MAP3K9 SNPs 
to alter breast cancer risk. A history of diabetes was associated with increased risk of breast 
cancer among those with the homozygote rare genotype for rs11844774, rs11622989, 
rs12883244, rs1115881, rs4902855, and rs17108548. For MAP3K9 rs11625206, 
rs11628333, rs10143031, rs8022269, and rs11624934, a history of diabetes in conjunction 
with the homozygote common allele genotype were associated with increased breast cancer 
risk.
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Although the overall MAPK pathway was not statistically significant, several MAPK genes 
were associated with breast cancer risk. MAP3K9 appeared to make the largest contribution 
to risk through its overall effect on breast cancer risk that was stronger with increasing level 
of IA. Several SNPs in MAP3K9 were associated with ER+/PR+ tumors specifically and 
showed interaction with DOBS, folate, obesity, alcohol intake, cigarette smoking, and a 
history of diabetes. In addition to MAP3K9, several other MAPK genes had multiple SNPs 
that jointly altered breast cancer risk with diet and lifestyle exposures. The patterns of 
association across diet and lifestyle factors with similar biological properties were similar 
for the same SNPs within genes, providing support that associations may be more than 
chance findings.
There is a continuum of decreasing breast cancer incidence rates across the spectrum of 
European to IA ancestry [29], hence our focus on differences in breast cancer risk by genetic 
ancestry. The admixed population of women living in the Southwestern United States, 
California, and Mexico included in this study allows us to examine this continuum. We 
observed the strongest associations for MAP3K9, the only gene with overall statistical 
significance, among those with the highest IA ancestry. For most SNPs we observed a 
continuum of risk across ancestry groups. MAP3K9 was most strongly associated among 
women with the highest IA ancestry and multiple SNPs in this gene interacted with a history 
of diabetes to alter risk of breast cancer. At a population level, rates of diabetes and 
metabolic syndrome are higher among Hispanic, Native American and Mexican women than 
among NHW women [45–47]. While assessment of interaction of diet and lifestyle factors 
within ancestry groups would be desirable, our power was limited to meaningfully evaluate 
these 3-way interactions.
Several patterns of association emerged when evaluating interactions between dietary 
variables and MAPK genes and breast cancer risk. For example significant interactions were 
observed with breast cancer risk for MAPK1 and DOBS, dietary fiber and folate; DUSP4 
rs2056025 interacted with both DOBS and dietary folate; MAPK8 rs10508901 interacted 
with total calories, fiber, and folate intake. Additionally, directions of association for high 
and low risk genotype and high and low risk lifestyle group were similar for factors 
expected to have similar mechanisms, such as DOBS, folate, and fiber having a similar 
effect, but opposite of those observed for total calories. Patterns of interaction by lifestyle 
factors also showed consistency across SNPs. For example four of the five SNPs in 
MAP3K9 shown to interact with pre-menopausal obesity also interacted with a history of 
diabetes. The two MAP3K9 SNPs interacting with alcohol intake also interacted with 
cigarette smoking.
These patterns of association support the reported mechanisms of MAPK genes that include 
activation by stimuli such as growth factors, inflammation, cytokines, and stress [1]. The 
JNK pathway, which was associated with breast cancer risk in these data, is involved in 
regulating responses to stress, inflammation, and apoptosis and is activated by radiation, 
environmental stresses, and growth factors. MAP3K9 appeared to be one of the most 
important MAPK genes with breast cancer in our population, both in terms of independent 
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risk and its interactive effects with diet and lifestyle factors. MAP3K9, also known as mixed-
lineage kinase 1 (MLK1), is instrumental in the regulation of the JNK pathway that is 
associated with normal and malignant cellular growth and division [48]. Other genes that 
regulate the JNK and ERK pathways, including MAP3K7 and MAP3K, also showed frequent 
interaction with diet and lifestyle factors. It is possible that response to diet and lifestyle 
factors is influenced by variation in genes at the activation point of these pathways. Dietary 
factors that influence oxidative balance may modify the effects of genes that respond to 
oxidative stress and inflammation. Cigarette smoking also could influence oxidative stress 
and importantly influence the effects of these genes to respond to stress. It could be further 
hypothesized that having a homozygote variant genotype of MAP3K9 makes individuals 
more sensitive to the effects of obesity or diabetes resulting in activation of JNK-signaling 
pathway that in turn regulates cell growth, differentiation, and apoptosis and ultimately 
cancer risk. The JNK pathway has been shown previously to be involved in the development 
of obesity and type 2 diabetes [3]; our data suggest significant interaction between BMI and 
a history of diabetes with MAP3K9. MAP3K7 is associated with transforming-growth factor 
β and bone morphogenetic protein signaling, both of which have been shown to influence 
breast cancer risk [49–51]; MAP3K1 and MAP3K3 enhance transcription of NFκB which is 
a key regulator of inflammatory response and associated with numerous cancers.
Few studies have examined genetic variation in MAPK genes and risk of cancer in general or 
breast cancer specifically. The variant allele of MAP3K1 rs889312 has been associated with 
increased breast cancer in a GWAS of European women [52] and among women with ER− 
tumors [53], although we did not observe a significant association with this SNP. Studies 
that evaluated interaction between this SNP and BMI did not observe a significant 
association with breast cancer risk [54]. However, SNPs in MAPK genes have been shown 
to interact with diet and lifestyle factors to alter colon cancer risk [55,56]. A study of breast 
tumors by Stephens and colleagues [57], concluded that MAP3K1 may harbor an important 
driver mutation. Hori and colleagues showed that ERα is regulated by MAPK and breast 
tumors that overexpressed ERK1, JNK1, and p38 proteins had more invasive tumor growth 
[58]. Given the biological role of MAPK genes there is support for an association, although 
previous studies have not examined polymorphisms in these genes and breast cancer risk.
The study has several strengths, including a large sample of Hispanic, NHW, and Mexican 
women, the assessment of AIMs that allowed examination of the continuum of European to 
IA ancestry, and our ability to look at interactions of key diet and lifestyle factors with these 
genes. While the information provided is novel and insightful to the pathways being studied, 
other MAPK genes and other diet and lifestyle factors that we did not have data on also may 
contribute to breast cancer risk and further illuminate these findings. A strength is our 
utilization of ARTP to evaluate the overall pathway and gene associations. This statistical 
method weighs the importance of the gene. Unfortunately ARTP has not been modified at 
this time to evaluate gene*environment interactions. Additionally, although we have limited 
information on functionality of SNPs associated with breast cancer, identification of similar 
associations for multiple SNPs within genes and patterns of interaction across genes and diet 
and lifestyle factors provides support for observed associations. Differences in dietary 
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patterns by level of ancestry could influence ability to detect associations for various 
ancestry groups.
In conclusion, our findings suggest that several MAPK genes were associated with breast 
cancer risk, although MAP3K9 appeared to make the largest contribution to breast cancer 
risk. Several MAPK genes and SNPs, especially in MAP3K9, interacted with DOBS, dietary 
folate and fiber, total calories, obesity, alcohol intake, cigarette smoking, and a history of 
diabetes. The patterns of association across diet and lifestyle factors with similar biological 
properties for the same SNPs within genes provide support for the associations. Our findings 
suggest that this pathway may be most important for those women.
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